You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR MEBENDAZOLE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MEBENDAZOLE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00116493 ↗	Severe Anemia Treatment Trials, Pakistan	Completed	Aga Khan University	Phase 3	2004-04-01	The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT00116493 ↗	Severe Anemia Treatment Trials, Pakistan	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	2004-04-01	The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT01050452 ↗	Safety and Efficacy of Drug Combinations Against Trichuris Trichiura	Completed	DBL -Institute for Health Research and Development	N/A	2007-10-01	This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MEBENDAZOLE

Condition Name

Chart
Table

Condition Name for MEBENDAZOLE
Intervention	Trials
Helminthiasis	3
Anemia	2
Anaplastic Astrocytoma	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MEBENDAZOLE
Intervention	Trials
Helminthiasis	7
Infections	6
Infection	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MEBENDAZOLE

Trials by Country

Map
Table

Trials by Country for MEBENDAZOLE
Location	Trials
United States	4
Tanzania	4
Ethiopia	3
India	2
Egypt	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MEBENDAZOLE
Location	Trials
Maryland	2
Florida	1
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MEBENDAZOLE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MEBENDAZOLE
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	8
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MEBENDAZOLE
Clinical Trial Phase	Trials
Completed	18
Recruiting	5
Unknown status	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MEBENDAZOLE

Sponsor Name

Chart
Table

Sponsor Name for MEBENDAZOLE
Sponsor	Trials
Bill and Melinda Gates Foundation	3
Swiss Tropical & Public Health Institute	3
University Ghent	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MEBENDAZOLE
Sponsor	Trials
Other	81
Industry	9
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.